Thomas J. Hoerger

RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.

Search Results

Filter by Type

Filter by Year

Filter by Focus Area

Filter by Solution

Filter by Center

Search Results

Search behavior and choice of physician in the market for prenatal care

Cost-effectiveness of intensive glycemic control, intensified hypertension control, and serum cholesterol level reduction for type 2 diabetes

An Evaluation of Cost-sharing to Finance a Diet and Physical Activity Intervention to Prevent Diabetes

Understanding participants' perceptions of access to and satisfaction with chronic disease prevention programs

The cost-effectiveness of screening for pre-diabetes among overweight and obese U.S. adults

Preventing non-communicable diseases using pricing policies: Lessons for the United States from global experiences and local pilots

'Profit' variability in for-profit and not-for-profit hospitals

Cost-effectiveness of osteoporosis screening and treatment with hormone replacement therapy, raloxifene, or alendronate

Medicare beneficiary satisfaction with durable medical equipment suppliers

The cost-effectiveness of routine office-based identification and subsequent medical treatment of primary open-angle glaucoma in the United States

Treatment patterns and distribution of low-density lipoprotein cholesterol levels in treatment-eligible United States adults

Influencing the economics of health care in the future

Patient health utility equations for a type 2 diabetes model

Health Affairs: Diabetes prevention programs could save $5.7B

A new type 2 diabetes microsimulation model to estimate long-term health outcomes, costs, and cost-effectiveness

Cost effectiveness of pramipexole in Parkinson's disease in the US

Cost-Effectiveness of Hepatitis B Vaccination in Adults With Diagnosed Diabetes

Using costs in cost-effectiveness models for chronic diseases: lessons from diabetes

A cost-benefit analysis of lipid standardization in the United States

Durable Medical Equipment Prices